This is an abridged version of a post from Dr. Gaudensia Nzembi Mutua, a research physician at the Kenya AIDS Vaccine Initiative (KAVI) based in Nairobi, Kenya.

Dr. Mutua speaking at the European R&D global health meeting in Madrid, Spain. Photo courtesy of Planeta Salud ©
According to UNAIDS, 59% of all people living with HIV in sub-Saharan Africa are women. What is less well known is the immense contribution African women have made and continue to make to HIV-prevention research. The first clues that an AIDS vaccine might be possible came from African women. These were a small subset of sex workers in Nairobi and the Gambia who had been repeatedly exposed to HIV but not infected; they were apparently able to resist the virus. The finding sparked a search—which continues to date—for a vaccine that can teach the body to protect itself against HIV.
Today it is International Women’s Day, a time to celebrate the contributions women have made to HIV-prevention research. Female researchers, volunteers, advocates and decision-makers around the world dedicate themselves to this cause. It is now more urgent than ever that we sustain support for efforts to develop new tools to prevent HIV infection, specifically ones that address the varied needs of women.
A safe and effective HIV vaccine, used in combination with other prevention strategies, is our best hope of ending the AIDS pandemic. But developing new HIV prevention tools takes resources, people, and time—in the laboratory, in safety tests, and in clinical trials. Sustained investments in HIV vaccine research are therefore critical; so is political support.
African women are playing a key role in the global endeavor to stop HIV/AIDS, and in the years to come will continue to be a central force in making an HIV vaccine a reality.






